0690 Noninvasive Tests for Hepatic Fibrosis (2) - Aetna
United States as the HCV -FibroSure Test (LabCorp, Burlington, NC) (also known as HCV -FibroSure, ASH FibroSure, NASH FibroSure) are serum biochemical tests for the assessment of fibrosis and necroinflammatory activity, respectively. The HCV -FibroSure Test includes the following five markers, as well as age and gender: alpha2 ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- multianalyte assays with algorithmic analysis for the regence
- 0690 noninvasive tests for hepatic fibrosis
- 921 noninvasive techniques for the evaluation and monitoring of
- 0690 noninvasive tests for hepatic fibrosis 1 aetna
- fibrotest fibrosure evicore
- lab management guidelines v2 0 2019 fibrotest fibrosure evicore
- multianalyte assays with algorithmic analysis for the evaluation and
- 0690 noninvasive tests for hepatic fibrosis aetna
- non invasive testing for liver fibrosis
- combination of serum markers for liver fibrosis in the aapc
Related searches
- icd 10 code for hepatic function screening
- icd 10 diagnosis code for hepatic lesion
- 2021 icd 10 code for hepatic encephalopathy
- icd 10 code for hepatic encephalopathy acute
- icd 10 for hepatic encephalopathy
- icd 10 for hepatic dysfunction
- medications for hepatic encephalopathy
- treatment for hepatic encephalopathy
- medication for hepatic encephalopathy
- antibiotics used for hepatic encephalopathy
- medications used for hepatic encephalopathy
- flagyl for hepatic encephalopathy